Potential for targeting aggressive breast cancers
Wednesday, February 12, 2014 - 17:51
in Health & Medicine
A new study shows that targeting Twist, a nuclear protein that is an accelerant of the epithelial-mesenchymal transition (EMT) program in human cells, may provide an effective approach for treating triple-negative breast cancer.
